CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response

CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response

Predicting the response to chemotherapy is a major goal of cancer research. Here the authors use CRISPR knockout screens in pancreatic ductal adenocarcinoma cells to identify deletions synergistic with MEK inhibitors.

Saved in:
Bibliographic Details
Main Authors: Karol Szlachta, Cem Kuscu, Turan Tufan, Sara J. Adair, Stephen Shang, Alex D. Michaels, Matthew G. Mullen, Natasha Lopes Fischer, Jiekun Yang, Limin Liu, Prasad Trivedi, Edward B. Stelow, P. Todd Stukenberg, J. Thomas Parsons, Todd W. Bauer, Mazhar Adli
Format: article
Language:EN
Published: Nature Portfolio 2018
Subjects:
Science
Q
Online Access:https://doaj.org/article/5878576fa2b34029942f52a332a9c423
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/5878576fa2b34029942f52a332a9c423

Similar Items